Isolated lymph node relapse cases demonstrated greater tumor-infiltrating lymphocyte burden at diagnosis, but did not demonstrate significant enrichment or depletion of BRCA1/2 mutation or gain of CCNE1, both known to be prognostic in ovarian carcinoma. The gene discussed is CCNE1; the disease is ovarian carcinoma.